Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 11-2025 | 08-2025 | 05-2025 | 02-2025 | 11-2024 | |
| Sales | 0 | 174 | 174 | 174 | 184 |
| Cost of Goods | 0 | N/A | N/A | N/A | 3 |
| Gross Profit | 0 | 174 | 174 | 174 | 181 |
| Operating Expenses | 1,574 | 2,863 | 3,924 | 2,925 | 2,875 |
| Operating Income | -1,574 | -2,689 | -3,750 | -2,751 | -2,691 |
| Other Income | -22 | -9 | -40 | 34 | -16 |
| Pre-tax Income | -1,596 | -2,697 | -3,791 | -2,717 | -2,707 |
| Income Tax | 2 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -1,598 | -2,697 | -3,791 | -2,717 | -2,707 |
| Minority Interests | -3 | -1 | -2 | -4 | -3 |
| Net Income | $-1,595 | $-2,696 | $-3,789 | $-2,713 | $-2,704 |
| EPS Basic Total Ops | -0.07 | -0.14 | -0.21 | -0.15 | -0.16 |
| EPS Basic Continuous Ops | -0.07 | -0.14 | -0.21 | -0.16 | -0.16 |
| EPS Diluted Total Ops | -0.07 | -0.14 | -0.21 | -0.15 | -0.16 |
| EPS Diluted Continuous Ops | -0.07 | -0.14 | -0.21 | -0.16 | -0.16 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.13 | -0.21 | -0.15 | -0.16 |
| EBITDA(a) | $-1,557 | $-2,667 | $-3,720 | $-2,749 | $-2,658 |